. , , ,

,,,

-- — ,

.. , .. , .. , , .

, . , , [4, 5, 8].

, HLA , , , [1, 3, 5, 6, 9].

, .

17 (34 ) 1042 . , , –, .

Җ – , Җ ( CD3, CD4, CD8, CD4/CD8, CD16, CD19) [7], Ö [2], [14]. (a) (S) [10]. [15]. (.. , 1988).

52 .

HLABw22, HLADRMT3, HLADR4 [1113].

.

() 35 56 29,4% (c2) 4,87 6,60 . (Px) HLA 35 56. HLA 12, 14, 22, 51, 18, 21, 27, 41; 7, 8, 16, 40 . (HLA A1A11) (. 1).

, 12, 14 , 22, 35, 51, 56 . 35 56 . HLA 2.

3. (n=4) 12 14 . (n=13) , (n=5) .

HLA 12 14 (<0,001) CD4+ CD16+ (p<0,05). 22, 35, 51, 56 (p<0,05) CD3+, CD8+, CD16+ CD19+ , . .

15 (87%), IgG (20,70,95 /) Ig (2,260,03 /), 11,630,25 1,640,061 /.

, , S, a, (. 4). 11 (64,7%), 12 (70,6%) 6 (35,3%) .

, .

, 12, 14, 22, 35, 51, 56 , . , , G . .

1. .. HLA . , 1999. 194 .

2. .., .., .. . // . . . ., 1989. 40 .

3. .. . ., , 1983. 208 .

4. .., .. (, ). ., 1998. 203.

5. .. , : . . ... ... , 2000. 22 .

6. .. , . //. .1998. 4. . 229301.

7. .. . // . . 1978. 7. . 8 15.

8. .., .., .., .. . //. . 1991. 4. . 4953

9. .., ..//Int. J.Immunorehabil. 1998. 10. . 3038.

10. .., .., .., .. // . , 1998. . 273277.

11. Bodmer W. //HLA 1997 Eds P.Terasaki, D.Gjertson. 1998. P. 17.

12. Boutimzine N., Laghmari A., Ouazzani I., Ibrahimy W., Mohcine Z. // J. Fr. Ophtalmol. 1998. Dec; 21 (10). P. 746754

13. DesarnauldsA.B., BorruatF.X., HerbortC.P., SpertiniF. //Klin.Monatsbl.Augenheilkd. 1996. May. 208 (5). P. 301302

14. Mancini G. et al. //Int. Immunochem. 1965. Vol .2 .235254.

15. Terasaki P.I., Bernoco D., Park M.S. et al. //Amer.J.Clin.Pathol. 1978. Vol. 69. P. 103120



: - 150 . - 700 . - 2500 . .. , .. , .. , , . , .

 

 

 

! , , , .
. , :